Changes in FeNO, d-ROMs, and BH4 by Intravenous L-Arginine in Children and Its Putative Role in Asthma Treatment
Naho Yamamoto,Saki Kasuga,Daijiro Kabata,Myu Ono,Sakura Ando,Taisuke Hashimoto,Shiori Fujikawa,Hiroko Fujitani,Ayumi Shintani,Takashi Hamazaki
DOI: https://doi.org/10.2147/jaa.s445203
2024-03-20
Journal of Asthma and Allergy
Abstract:Naho Yamamoto, 1 Saki Kasuga, 1 Daijiro Kabata, 2 Myu Ono, 1 Sakura Ando, 1 Taisuke Hashimoto, 1 Shiori Fujikawa, 1 Hiroko Fujitani, 3 Ayumi Shintani, 2 Takashi Hamazaki 1 1 Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; 2 Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; 3 Fujitani Clinic, Osaka, Japan Correspondence: Naho Yamamoto, Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan, Tel +81-6-6645-3816, Fax +81-6-6636-8737, Email Purpose: Pteridines are metabolites of tetrahydrobiopterin (BH 4 ), being coenzymes for nitric oxide synthase (NOS). No study has clarified the relationship among pteridines and NOS, fractional exhaled nitric oxide (FeNO) generated by pteridines, and reactive oxygen species. In this study, we administered arginine, a precursor of NO, and confirmed changes in the levels of pteridines, FeNO, and reactive oxygen species and their relationship to clarify the pathogenesis of airway inflammation in which oxidative stress is involved, such as bronchial asthma. Patients and Methods: This is a prospective, randomized open-label study. Children, aged 2 to 15 years, who were scheduled for growth hormone stimulation tests and were able to undergo a respiratory function test were recruited. They were randomly divided into two groups: arginine-administered and control groups. In the former, L-arginine hydrochloride was intravenously administered. After administration, the levels of diacron-reactive oxygen metabolites (d-ROMs), serum pteridines, serum amino acids, and fractional exhaled NO (FeNO) were measured. Results: We analyzed 15 children aged 4 to 14 years. In the arginine-administered group, there was an increase in the FeNO level and a decrease in the d-ROMs level, reaching a peak 30 min after administration, compared with the control group. In addition, there was a decrease in the serum biopterin level and an increase in the d-ROMs level, reaching peak 60 min after administration. Conclusion: The administration of L-arginine increased the NO level and decreased the d-ROMs level. Due to this, biopterin may be consumed and decreased, leading to an increase in the d-ROMs level. As a reduction in reactive oxygen species leads to the relief of inflammation, arginine and biopterin may be useful for inhibiting inflammation. Keywords: asthma, biomarker, biopterin, child, FeNO, d-ROMs Concerning bronchial asthma, it was reported that the fractional exhaled nitric oxide (FeNO) level was increased in asthma patients with eosinophilic inflammation of the airway. 1,2 This parameter is particularly useful as a marker of the severity of asthma or for monitoring; therefore, it is used in clinical practice. 3–6 Nitric oxide (NO) is generated in a synthetic pathway from L-arginine to L-citrulline in the presence of tetrahydrobiopterin (BH 4 ) as a coenzyme and nitric oxide synthase (NOS) as a catalyst. 7,8 NOS has been isolated into three isoforms: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS), which affects FeNO production. 9 BH 4 acts as an essential coenzyme for all subtypes of NOS. In the respiratory system, iNOS produces NO and increases FeNO concentrations above normal in the presence of airway inflammation. NO has a variety of roles in the body, especially in the respiratory tract, NO relaxes airway smooth muscle and acts as an airway protective agent. In addition, NO works together with active oxygen to form free radicals, which can cause inflammation and damage to the lungs and airways. In other words, NO has both airway protective and inflammatory effects. 10 Previous studies indicated that oral administration or inhalation of L-arginine transiently increased the body's (including expired air) level of NO. 11,12 When BH 4 is insufficient, which is a coenzyme for the synthetic pathway, NOS produces reactive oxygen species instead of NO (Figure 1). 13 There is evidence that allergic diseases are caused by excessively produced reactive oxygen species/oxidative stress. Previous studies have also reported that oxidative stress played an important role in asthma. 14–17 Interventional studies with arginine involving patients with asthma have also been conducted. 18,19 However, no study has clarified changes in BH 4 or reactive oxygen species associated with the arginine-administration-related promotion of NO synthesis. Figure 1 The metabolic pathway of NO g -Abstract Truncated-
immunology,allergy,respiratory system